AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 237 filers reported holding AMICUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $19,351,000 | +12.0% | 1,675,373 | -7.4% | 0.13% | +12.1% |
| Q3 2021 | $17,284,000 | +3.9% | 1,809,792 | +4.9% | 0.12% | +2.7% |
| Q2 2021 | $16,634,000 | +552.1% | 1,725,528 | +568.3% | 0.11% | +465.0% |
| Q1 2021 | $2,551,000 | +44.5% | 258,215 | +42.5% | 0.02% | +17.6% |
| Q4 2019 | $1,765,000 | +1053.6% | 181,176 | +848.6% | 0.02% | +750.0% |
| Q3 2019 | $153,000 | -28.8% | 19,100 | +11.0% | 0.00% | -33.3% |
| Q2 2019 | $215,000 | -76.2% | 17,200 | -77.0% | 0.00% | -76.9% |
| Q3 2018 | $903,000 | +8.9% | 74,724 | +40.7% | 0.01% | 0.0% |
| Q2 2018 | $829,000 | +148.9% | 53,100 | -5.0% | 0.01% | +116.7% |
| Q3 2014 | $333,000 | +50.0% | 55,885 | -15.8% | 0.01% | +50.0% |
| Q2 2014 | $222,000 | +226.5% | 66,400 | +129.7% | 0.00% | +300.0% |
| Q4 2013 | $68,000 | -78.3% | 28,912 | -78.6% | 0.00% | -80.0% |
| Q3 2013 | $313,000 | – | 135,046 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |